While MSH2-/- lymphomas developed 3–4 months post-transplantation in thymus-intact WT recipients, no T-lymphomas was observed in thymectomized recipients of MSH2-/- BM cells observed for up to 9 months (Fig 4B). The gene discussed is MSH2; the disease is lymphoma.